Clinical Trial Update: Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer

View source ↗

Summary

This clinical trial compares intraperitoneal chemotherapy with intravenous chemotherapy for recurrent ovarian cancer, and it is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Far Eastern Memorial Hospital | Conditions: Intravenous Chemotherapy Versus Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer | Status: NOT_YET_RECRUITING